article Experts explore the future of iPSC-based cell therapies 19 February 2025 | By Discover the transformative potential of iPSC-based therapies in regenerative medicine, alongside their challenges including scalability, safety and targeted delivery.
whitepaper Executive summary: Scale-up strategies for late-stage cell therapies 6 January 2023 | By Catalent Discover how Catalent can help you achieve efficiencies and develop a robust, reproducible manufacturing plan for late-stage and commercial launch.
video Webinar: Plasmid platform facilitates transition to clinic 4 November 2022 | By Catalent Discover how a plasmid DNA manufacturing platform process is helpful from preclinical studies to scaling production for late-stage and commercial needs.